{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:50:58Z","timestamp":1781650258031,"version":"3.54.5"},"reference-count":22,"publisher":"Japanese Society of Internal Medicine","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,8,15]]},"DOI":"10.2169\/internalmedicine.6931-20","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T22:06:25Z","timestamp":1615154785000},"page":"2697-2700","source":"Crossref","is-referenced-by-count":7,"title":["Painless Panniculitis upon the Treatment of Clinically Amyopathic Dermatomyositis with Anti-MDA5 Antibody"],"prefix":"10.2169","volume":"60","author":[{"given":"Dai","family":"Kishida","sequence":"first","affiliation":[{"name":"Department of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Ushiyama","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Shimojima","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Ueno","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichi","family":"Kurashina","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takushi","family":"Shirai","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Sekijima","sequence":"additional","affiliation":[{"name":"Department of Medicine (Neurology & Rheumatology), Shinshu University School of Medicine, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Mainetti C, Beretta-Piccoli BT, Selmi C. Cutaneous Manifestations of Dermatomyositis: a Comprehensive Review. Clin Rev Allergy Immunol 53: 337-356, 2017.","DOI":"10.1007\/s12016-017-8652-1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Hansen CB, Callen JP. Connective tissue panniculitis: lupus panniculitis, dermatomyositis, morphea\/scleroderma. Dermatol Ther 23: 341-349, 2010.","DOI":"10.1111\/j.1529-8019.2010.01334.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gerami P, Schope JM, McDonald L, et al. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 54: 597-613, 2006.","DOI":"10.1016\/j.jaad.2005.10.041"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Braunstein I, Werth VP. Update on management of connective tissue panniculitides. Dermatol Ther 25: 173-182, 2012.","DOI":"10.1111\/j.1529-8019.2012.01489.x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Requena L, Sanchez Yus E. Panniculitis. Part II. Mostly lobular panniculitis. J Am Acad Dermatol 45: 325-361, 2001.","DOI":"10.1067\/mjd.2001.114735"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Santos-Briz A, Calle A, Linos K, et al. Dermatomyositis panniculitis: a clinicopathological and immunohistochemical study of 18 cases. J Eur Acad Dermatol Venereol 32: 1352-1359, 2018.","DOI":"10.1111\/jdv.14932"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Moghadam-Kia S, Oddis CV, Aggarwal R. Anti-MDA5 antibody spectrum in western world. Curr Rheumatol Rep 20: 78, 2018.","DOI":"10.1007\/s11926-018-0798-1"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Kurtzman DJB, Vleugels RA. Anti-melanoma differentiation-associated gene 5 (MDA5) dermatomyositis: a concise review with an emphasis on distinctive clinical features. J Am Acad Dermatol 78: 776-785, 2018.","DOI":"10.1016\/j.jaad.2017.12.010"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Sato S, Kuwana M, Fujita T, Suzuki Y. Anti-CADM-140\/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol 23: 496-502, 2013.","DOI":"10.3109\/s10165-012-0663-4"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Fiorentino D, Chung L, Zwerner J, Rosen A, Casciola-Rosen L. The mucocutaneous and systemic phenotype of dermatomyositis patients with antibodies to MDA5 (CADM-140): a retrospective study. J Am Acad Dermatol 65: 25-34, 2011.","DOI":"10.1016\/j.jaad.2010.09.016"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Labrador-Horrillo M, Martinez MA, Selva-O'Callaghan A, et al. Anti-MDA5 antibodies in a large Mediterranean population of adults with dermatomyositis. J Immunol Res 2014: 290797, 2014.","DOI":"10.1155\/2014\/290797"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hasegawa A, Shimomura Y, Kibune N, Koshio J, Umemori Y, Abe R. Panniculitis as the initial manifestation of dermatomyositis with anti-MDA5 antibody. Clin Exp Dermatol 42: 551-553, 2017.","DOI":"10.1111\/ced.13128"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Galli S, Naudi G, Guler SA, et al. Kissed by MDA-5: lobular panniculitis of the cheek as an initial symptom of dermatomyositis. Rheumatology 59: 1189, 2019.","DOI":"10.1093\/rheumatology\/kez567"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Hattori Y, Matsuyama K, Takahashi T, Shu E, Kanoh H, Seishima M. Anti-MDA5 antibody-positive dermatomyositis presenting with cellulitis-like erythema on the mandible as an initial symptom. Case Rep Dermatol 10: 110-114, 2018.","DOI":"10.1159\/000488077"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Agullo A, Hinds B, Larrea M, Yanguas I. Livedo Racemosa, reticulated ulcerations, panniculitis and violaceous plaques in a 46-year-old woman. Indian Dermatol Online J 9: 47-49, 2018.","DOI":"10.4103\/idoj.IDOJ_72_17"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Pau-Charles I, Moreno PJ, Ortiz-Ib\u00e1\u00f1ez K, et al. Anti-MDA5 positive clinically amyopathic dermatomyositis presenting with severe cardiomyopathy. J Eur Acad Dermatol Venereol 28: 1097-1102, 2014.","DOI":"10.1111\/jdv.12300"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Azevedo PO, Castellen NR, Salai AF, Barbosa FS, Alves C, Pinto CAL. Panniculitis associated with amyopathic dermatomyositis. An Bras Dermatol 93: 119-121, 2018.","DOI":"10.1590\/abd1806-4841.20186597"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Abdul-Wahab A, Holden CA, Harland C, Patel S. Calcific panniculitis in adult-onset dermatomyositis. Clin Exp Dermatol 34: e854-856, 2009.","DOI":"10.1111\/j.1365-2230.2009.03603.x"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Sabroe RA, Wallington TB, Kennedy CT. Dermatomyositis treated with high-dose intravenous immunoglobulins and associated with panniculitis. Clin Exp Dermatol 20: 164-167, 1995.","DOI":"10.1111\/j.1365-2230.1995.tb02675.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Carroll M, Mellick N, Wagner G. Dermatomyositis panniculitis: a case report. Australas J Dermatol 56: 224-226, 2015.","DOI":"10.1111\/ajd.12172"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Carrera E, Lobrinus JA, Spertini O, Gherardi RK, Kuntzer T. Dermatomyositis, lobar panniculitis and inflammatory myopathy with abundant macrophages. Neuromuscul Disord 16: 468-471, 2006.","DOI":"10.1016\/j.nmd.2006.05.008"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Skorpen CG, Hoeltzenbein M, Tincani A, et al. The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation. Ann Rheum Dis 75: 795-810, 2016.","DOI":"10.1136\/annrheumdis-2015-208840"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/16\/60_6931-20\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T14:52:55Z","timestamp":1671547975000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/16\/60_6931-20\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,15]]},"references-count":22,"journal-issue":{"issue":"16","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.6931-20","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,15]]},"article-number":"6931-20"}}